您的购物车当前为空
别名 Cenupatide acetate(1006388-38-0 Free base)
Cenupatide acetate 是一种尿激酶纤溶酶原激活物受体 (uPAR) 抑制剂,用于治疗与细胞迁移改变相关的疾病,例如癌症。

Cenupatide acetate 是一种尿激酶纤溶酶原激活物受体 (uPAR) 抑制剂,用于治疗与细胞迁移改变相关的疾病,例如癌症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 565 | In Stock | |
| 2 mg | ¥ 823 | In Stock | |
| 5 mg | ¥ 1,170 | In Stock | |
| 10 mg | ¥ 1,950 | In Stock | |
| 25 mg | ¥ 3,520 | In Stock | |
| 50 mg | ¥ 4,970 | In Stock | |
| 100 mg | ¥ 7,230 | In Stock | |
| 500 mg | ¥ 14,300 | In Stock |
| 产品描述 | Cenupatide acetate is an urokinase plasminogen activator receptor (uPAR) inhibitor for treating disorders associated altered cell migration, such as cancer. |
| 体内活性 | Cenupatide通过抑制uPAR与甲酰肽受体(FPRs)的结合,在链脲佐菌素(STZ)诱导的大鼠糖尿病模型中改善肾损伤[1]。 |
| 别名 | Cenupatide acetate(1006388-38-0 Free base) |
| 分子量 | 677.8 |
| 分子式 | C30H51N11O7 |
| Smiles | C[C@@](NC([C@H](CCCNC(N)=N)NC(C(C)(C)NC([C@@H](NC(C)=O)CCCNC(N)=N)=O)=O)=O)(C(N)=O)CC1=CC=CC=C1.CC(O)=O |
| Sequence | Arg-Aib-DL-Arg-DL-aMePhe |
| Sequence Short | RXRX |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | H2O: 10 mg/mL (14.8 mM), Sonication is recommended. DMSO: 5 mg/mL (7.4 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO/H2O
H2O
| ||||||||||||||||||||||||||
评论内容